• The Most Radical Trumpcare Bill Yet – Tell your senators to VOTE NO on Graham-Cassidy.
    September 20, 2017
    Senate Republicans are making one last push to repeal the Affordable Care Act (ACA) and gut Medicaid and their latest Trumpcare bill known as Graham-Cassidy is the most radical one yet! Pushed by Senators Lindsey Graham (R-SC) and Bill Cassidy (R-LA), the bill repeals the ACA’s consumer protections, allowing insurance companies to once again discriminate against ...
  • FDA Approvals: On a Fast-Track to Disaster
    September 14, 2017
    By Caila Brander, NWHN Policy Fellow Most of us want to be confident when we start a newly prescribed treatment that the medication we take will improve the ailment we seek to treat. We believe that our drugs have been tested and proven effective. We assume that the U.S. Food and Drug Administration (FDA) verifies that ...
  • The National Women’s Health Network Celebrates Senate’s Failure to Pass ACA Repeal
    July 28, 2017
    For Immediate Release: Contact: Sarah Christopherson, schristopherson@nwhn.org Telephone: (202) 796-3065 The National Women’s Health Network Celebrates Senate’s Failure to Pass ACA Repeal Washington, D.C. – After a dramatic late night vote to repeal key provisions of the Affordable Care Act (ACA) failed 49 to 51, Senate Republicans announced today that the Senate would move on to new legislation. ...
  • The National Women’s Health Network Responds to Announcement that the Senate Won’t Vote on Trumpcare This Week
    June 27, 2017
    For Immediate Release Contact: Sarah Christopherson, schristopherson@nwhn.org Telephone: (202) 796-3065 The National Women’s Health Network Responds to Announcement that the Senate Won’t Vote on Trumpcare This Week Washington, D.C. – In response to widespread public outrage, Senate Republicans announced today that they were postponing a planned vote on their bill (also known as “Trumpcare”) to repeal parts of the ...
  • The NWHN Responds to Confirmation of Scott Gottlieb to Head the FDA
    May 10, 2017
    For Immediate Release Shaniqua Seth Email: sseth@nwhn.org Telephone: (301) 965-0097   The NWHN Responds to Confirmation of Scott Gottlieb to Head the FDA: His Views are Harmful to Women’s Health   Washington, D.C. – On Tuesday, the Senate voted to confirm conservative physician and former Bush official Scott Gottlieb to head the U.S. Food and Drug Administration (FDA) in a 57-42 vote. The ...
  • NWHN is Outraged — House Votes to Take Away Health Care!
    May 4, 2017
    FOR IMMEDIATE RELEASE May 4, 2017 Contact: Shaniqua Seth at sseth@nwhn.org or (301) 965-0097   Washington, DC – Today, the House of Representatives voted 217 – 213 to repeal the Affordable Care Act (ACA) and pass Trump’s American Health Care Act (AHCA). This harmful legislation was rushed to the House floor and voted on before the full implications of ...
  • The National Women’s Health Network Opposes Gottlieb’s Nomination as FDA Commissioner
    March 13, 2017
    FOR IMMEDIATE RELEASE: March 13, 2017 Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 Washington, D.C. – On Friday, the White House announced the nomination of conservative physician and former Bush official Scott Gottlieb as commissioner of the Food and Drug Administration (FDA). The National Women’s Health Network has strong concerns that if Dr. Gottlieb is ...
  • The National Women’s Health Network Opposes Nomination of Judge Neil Gorsuch to the U.S. Supreme Court
    February 1, 2017
    FOR IMMEDIATE RELEASE Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 Washington, D.C. – For ten months, Senate Republicans have blocked consideration of Judge Merrick Garland, President Obama’s centrist pick, preferring to keep the seat vacant. Having set that precedent, the Senate should now take the time necessary to carefully vet far-right Judge Neil Gorsuch and ...
  • FDA Takes Steps to Protect Women’s & Consumer Health over Industry Profits
    January 23, 2017
    For Immediate Release Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 WASHINGTON, DC — Last week, the U.S. Food and Drug Administration released a 63-page memo regarding the dissemination of information about off-label use of medical products. The memo explains that drug makers need to provide evidence of the safety and effectiveness of the medical products ...
  • Health Advocates Issue One-Year Report Card on Addyi, the Female Libido Drug
    August 18, 2016
    FOR IMMEDIATE RELEASE Contact: Shaniqua Seth at sseth@nwhn.org or 202.682-2640, ext. 225 WASHINGTON, DC – August 18th marks the one-year anniversary of the Food and Drug Administration’s (FDA) approval of flibanserin (brand name: Addyi), the so-called “female Viagra” pill. In light of recent developments, the National Women’s Health Network (NWHN) has issued a one-year report card. The report ...